Always room for more than one drug for any illness.
Lots of pharmas in competition with each other.
Cost comes into it, and Imugene promises to be affordable
where some other drugs are not. If IMU is chosen to work
in combo with Keytruda permanently, competition should not be
a worry as Keytruda's market is very well established already.
- Forums
- ASX - By Stock
- Vaccines
Always room for more than one drug for any illness. Lots of...
-
- There are more pages in this discussion • 50 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
|
|||||
Last
5.7¢ |
Change
0.003(5.56%) |
Mkt cap ! $417.2M |
Open | High | Low | Value | Volume |
5.5¢ | 5.8¢ | 5.2¢ | $2.499M | 45.00M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 1921794 | 5.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.7¢ | 1368288 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 286362 | 0.055 |
9 | 2036888 | 0.054 |
16 | 2736044 | 0.053 |
20 | 1943436 | 0.052 |
23 | 3206056 | 0.051 |
Price($) | Vol. | No. |
---|---|---|
0.057 | 378902 | 2 |
0.058 | 1552127 | 7 |
0.059 | 837099 | 8 |
0.060 | 2176188 | 16 |
0.061 | 1163926 | 6 |
Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online